These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2006-003727-37 A randomized, open label, multicentre trial to define the most effective haemoglobin concentration to start erythropoietin beta (neoRecormon) therapy in anaemic subjects with lymphoproliferative malig... not-yet-due
Completed, but no date Terminated 2011-001916-69 insulin therapy in non-diabetic adults with cystic fibrosis insuline therapie in cystic fibrosis patienten zonder diabetes bad-data
Ongoing 2013-004488-30 Targeting Antibiotics to Pseudomonas Aeruginosa in Small airways (TAPAS) study in patients with cystic fibrosis: pharmacokinetics (PK) Targeting van Antibiotica naar Pseudomonas Aeruginosa in de S... not-yet-due
Ongoing 2014-005467-32 A randomised controlled trial on the effect of laxative therapy in children with functional abdominal pain Een gerandomiseerde dubbelblinde placebo-gecontroleerde studie naar het effect van laxeren... not-yet-due
Ongoing 2016-004295-22 Treatment of thromBocytopenia with EltRombopag or Intravenous Immune Globulin (IVIG) Before and DurING Invasive Procedures in Patients with Immune ThrombocytoPenia. not-yet-due
Ongoing 2017-001382-24 Read Dutch instructions Dosis Salbutamol (Ventolin) bij de reversibiliteitsmeting not-yet-due
Ongoing 2017-003164-13 Antibiotic prophylaxis for children with recurrent respiratory infections: towards evidence-based guidelines not-yet-due
Ongoing 2017-003569-91 The effect of body weight on trough concentrations of DOACs in patients. not-yet-due
Ongoing 2020-005224-12 Elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis using tacrolimus, a drug - drug interaction study Elexacaftor/tezacaftor/ivacaftor in patienten met cystic fibrosis die tacrolimus ... not-yet-due
Not reported Terminated 2022-001393-58 POMPAE trial: Peri-Operative Magnesium infusion to Prevent Atrial fibrillation Evaluated. 2023-09-06 due-trials